A new ACE inhibitor and two new angiotensin receptor blockers for hypertension.
D000179:Acrylates / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000097:blood / Q000493:pharmacokinetics; D001565:Benzoates / Q000097:blood / Q000493:pharmacokinetics; D002986:Clinical Trials as Topic; D000075202:Contraindications; D004311:Double-Blind Method; D006207:Half-Life; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use*; D020913:Perindopril / Q000627:therapeutic use*; D000077333:Telmisartan; D013876:Thiophenes
D000179:Acrylates; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D007093:Imidazoles; D013876:Thiophenes; C068373:eprosartan; D000077333:Telmisartan; D020913:Perindopril